New Therapy Inogona Kunonoka Kufambira mberi kwechirwere cheAlzheimer

A BATA FreeRelease 1 | eTurboNews | eTN
Avatar of Linda Hohnholz
rakanyorwa Linda Hohnholz

Chirwere cheAlzheimer (AD) nekumwe dementia zvinokonzeresa kuremerwa kwehupfumi uye hutano hweveruzhinji pasi rese. Huwandu hwevanhu vanorarama nedementia huri kuramba huchiwedzera zvakanyanya nekuda kwekuchembera kwevanhu uye kukura. Mishonga yazvino inotenderwa yeAD ine zviratidzo uye hairatidzike seinokanganisa kufambira mberi kwechirwere.

Moleac akazivisa kuburitswa kweiyo ATHENE mhedzisiro yeongororo, yakaburitswa mu Journal of the American Medical Director Association (JAMDA).

Mishonga iyo inogona kunyatso kudzikamisa nzira yeAD kana yasvika padanho rekiriniki, inoramba iri chinhu chakakosha chisingakwaniriswe chinodiwa chekurapa. NeuroAiD™II yakaratidza kuva ne modulatory mhedzisiro pane amyloid precursor protein (APP) processing2 uye shanduko yeprotein yetau kuita abnormally phosphorylated uye aggregated mafomu3, pamwe neuro-regenerative uye neuro-restorative properties4. Migumisiro inobatsira yeNeuroAiD™II pakukanganiswa kwekuziva mabasa yakatove yakaratidzwa mukukuvara kwehuropi.

Chirwere cheAlzheimer's Therapy neNEurwaid (ATHENE) Chidzidzo chidzidzo chekutanga kuongorora kuchengetedzeka uye kushanda kweNeuroAiD™II munyoro kusvika pakati pevarwere veAD vakagadzikana pakurapa kwezviratidzo.

ATHENE yaive 6-mwedzi randomized kaviri-mapofu, placebo-inodzorwa kuyedza yakateverwa neyakavhurika label yekuwedzera yeNeuroAiD™II kurapwa kweimwe mwedzi 6. Zvidzidzo zve125 kubva kuSingapore zvakabatanidzwa mukutongwa, iyo yakarongedzwa neMemory Aging and Cognition Center, National University Health System, National Neuroscience Institute, uye St. Luke's Hospital, Singapore.

• NeuroAiD™ II yakaratidza kuchengetedzwa kwenguva refu sekuwedzera-kwerapi mu AD pasina kuwedzera kwevarwere vane zviitiko zvakakomba zvakashata kana zviitiko zvakashata.

• Kutanga kwekutanga kweNeuroAiD™II kwakapa kuvandudzwa kwenguva refu kwekuziva kuenzaniswa ne placebo (boka rekutanga rekutanga) rakayerwa neADAS-cog, nhamba inokosha pamwedzi ye9, uye inoderedza kuderera kwekufamba kwenguva.

ATHENE mhedzisiro yekudzidza inotsigira kubatsirwa kweNeuroAiD™II seyakachengeteka yekuwedzera-kurapa kune yakajairwa AD kurapwa sezvo chidzidzo chakawana humbowo hwekuwedzera kwakanyanya kwezviitiko zvakashata pakati peMLC901 ne placebo. Ongororo dzinoratidza kugona kweMLC901 mukudzikisira kufambira mberi kweAD izvo zvinoenderana nezvakamboburitswa zvekiriniki uye zvidzidzo zvekiriniki, zvichiita kuti ive inovimbisa kurapa kuvarwere veAD. Izvi mhedzisiro zvinoda kumwe kusimbiswa muzvidzidzo zvakakura uye zvakareba.                                                         

Izwi rakabva kuna Principal Investigator

“Chirwere cheAlzheimer ndicho chinonyanya kukonzera dementia, chinotora chikamu che60-80% chezviitiko. Kusvikira kubvumidzwa kuchangobva kuitika kweaducanumab neFDA, pakanga pasina kurapwa kwechirwere cheAlzheimer's, uye kurapwa kwezviratidzo zviripo zvino kutsvaga kunonoka kwechinguva kuwedzera kwezviratidzo zvedementia uye kuvandudza hupenyu hweavo vane Alzheimer's nevanovachengeta. Nekudaro, panodiwa kupa varwere nevanovachengeta mukana wekukurumidza kuongororwa uye kurapwa kutsva.

Mhedzisiro inovimbisa yechidzidzo cheATHENE inofanirwa kunzwisiswa sechikamu chekuchinja kwepombi yeAlzheimer's Disease zvinodhaka kubva kuchiratidzo kuenda kuhosha dzekugadzirisa marapirwo. Chidzidzo ichi uye mamwe marapirwo angangove anofanirwa kuongororwa nemakiriniki akagadzirwa zvakanaka. "

Muzvinafundo Christopher Chen

Mutungamiriri, Memory Aging and Cognition Center, National University Health System uye Associate Purofesa, Dhipatimendi rePharmacology, Yong Loo Lin Chikoro cheMishonga, National University yeSingapore.

Nezvomunyori

Avatar of Linda Hohnholz

Linda Hohnholz

Editor mukuru we eTurboNews yakavakirwa muTN HQ.

Subscribe
Notify of
muenzi
0 Comments
Inline feedbacks
Ona zvese zvataurwa
0
Ndingade pfungwa dzako, ndapota taura.x
Govera ku...